Physician profile
Clyde R Varner
NPI 1316931256
$1,542.02
in general payments reported to CMS, 2019-2025
21 companies · $25.66 in 2025
The $25.66 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $57.24 · 2021: $376 · 2022: $335 · 2023: $347 · 2024: $48.14 · 2025: $25.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $421.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $175.09 | 2021-2025 | Sensight |
| Ucb, INC. | $165.30 | 2019-2023 | Briviact |
| Allergan, INC. | $164.38 | 2019-2021 | |
| Abbvie INC. | $131.48 | 2021-2023 | Qulipta, Botox |
| Biohaven Pharmaceutical Holding Company LTD. | $127.16 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $103.05 | 2019-2021 | |
| Acadia Pharmaceuticals INC | $100.31 | 2019-2023 | Nuplazid |
| Lilly USA, LLC | $99.27 | 2019-2022 | |
| Sk Life Science, INC. | $91.41 | 2020-2023 | |
| Novartis Pharmaceuticals Corporation | $75.76 | 2019-2023 | |
| Alexion Pharmaceuticals, INC. | $57.79 | 2021-2023 | Ultomiris |
| Acorda Therapeutics, INC | $52.19 | 2019-2020 | |
| Pfizer INC. | $40.63 | 2023-2024 | |
| Horizon Therapeutics Plc | $37.56 | 2021-2023 | Uplizna |
| Sunovion Pharmaceuticals INC. | $22.88 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $20.05 | 2023 | Rytary |
| Livanova USA, INC. | $19.55 | 2019 | |
| Tanabe Pharma America, INC. | $17.14 | 2019 | |
| Ge Healthcare | $15.81 | 2020 | |
| Emd Serono, INC. | $13.78 | 2019 | |
| Biogen, INC. | $11.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clyde Varner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.